Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Ross

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 26, 1998
Iodine-131 anti-B1 antibody for B-cell lymphoma: an update on the Michigan Phase I experienceR L Wahl, K R Zasadny, D MacFarlane, et al.
The Journal of Investigative Dermatology|May 1, 1993
Leukemic T cells from patients with cutaneous T-cell lymphoma demonstrate enhanced activation through CDw60, CD2, and CD28 relative to activation through the T-cell antigen receptor complexE R Hansen, G L Vejlsgaard, K D Cooper, et al.
The New England Journal of Medicine|August 12, 1993
Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibodyM S Kaminski, K R Zasadny, I R Francis, et al.
Blood|August 15, 2000
Radioimmunotherapy with iodine (131)I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experienceM S Kaminski, J Estes, K R Zasadny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphomaM S Kaminski, K R Zasadny, I R Francis, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 26, 1998
Iodine-131 anti-B1 antibody for B-cell lymphoma: an update on the Michigan Phase I experienceR L Wahl, K R Zasadny, D MacFarlane, et al.
The Journal of Investigative Dermatology|May 1, 1993
Leukemic T cells from patients with cutaneous T-cell lymphoma demonstrate enhanced activation through CDw60, CD2, and CD28 relative to activation through the T-cell antigen receptor complexE R Hansen, G L Vejlsgaard, K D Cooper, et al.
The New England Journal of Medicine|August 12, 1993
Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibodyM S Kaminski, K R Zasadny, I R Francis, et al.
Blood|August 15, 2000
Radioimmunotherapy with iodine (131)I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experienceM S Kaminski, J Estes, K R Zasadny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphomaM S Kaminski, K R Zasadny, I R Francis, et al.
Pageof 7